CRISPR Therapeutics

In News

Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely and Continuously Lower Cholesterol and Triglycerides After One Year - Cleveland Clinic Newsroom

Cleveland Clinic Newsroom - Aug 28, 2026

An Experimental One-Time Treatment for High Cholesterol Shows Promising Results - Time Magazine

Time Magazine - Aug 29, 2026

#ESC26: CRISPR Therapeutics to pursue highest dose of its lipid lowering gene editing therapy - Endpoints News

Endpoints News - Aug 28, 2026

CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026 - Yahoo Finance

Yahoo Finance - Aug 28, 2026

News: CMN Weekly (28 August 2026) - Your Weekly CRISPR Medicine News - CRISPR Medicine News

CRISPR Medicine News - Aug 28, 2026

An Experimental Single-Time Treatment Slashed Cholesterol for a Year - The New York Times

The New York Times - Aug 28, 2026

CRISPR Therapeutics (CRSP) Is Up 15.0% After Casgevy Label Expansion - What's Changed - simplywall.st

simplywall.st - Aug 26, 2026

$CRISPR Therapeutics (CRSP.US)$ - Moomoo

Moomoo - Aug 27, 2026

CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026 - Barchart.com

Barchart.com - Aug 28, 2026

CRISPR Therapeutics (CRSP) Is Up 15.0% After Casgevy Label Expansion - What's Changed - Sahm

Sahm - Aug 27, 2026

Citizens reaffirms CRISPR Therapeutics stock rating on gene therapy data - Investing.com

Investing.com - Aug 25, 2026

CRISPR Therapeutics (NASDAQ:CRSP) Trading 6.6% Higher - Here's What Happened - MarketBeat

MarketBeat - Aug 25, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment